Radiotherapy tumor volume for limited-stage small cell lung cancer: less is more.
作者信息
Levy Antonin, Faivre-Finn Corinne
机构信息
Department of Radiation Oncology, Institut d'Oncologie Thoracique (IOT), Gustave Roussy, Villejuif, France.
Univ Paris Sud, Université Paris-Saclay, Le Kremlin-Bicêtre, France.
出版信息
Ann Transl Med. 2020 Sep;8(17):1114. doi: 10.21037/atm.2020.04.45.
Abstract
摘要
相似文献
1
Radiotherapy tumor volume for limited-stage small cell lung cancer: less is more.局限期小细胞肺癌的放疗肿瘤体积：少即是多。
Ann Transl Med. 2020 Sep;8(17):1114. doi: 10.21037/atm.2020.04.45.
2
Predictive and prognostic value of tumor volume and its changes during radical radiotherapy of stage III non-small cell lung cancer : A systematic review.根治性放疗中 III 期非小细胞肺癌肿瘤体积及其变化的预测和预后价值：系统评价。
Strahlenther Onkol. 2018 Feb;194(2):79-90. doi: 10.1007/s00066-017-1221-y. Epub 2017 Oct 13.
3
Final report of a prospective randomized study on thoracic radiotherapy target volume for limited-stage small cell lung cancer with radiation dosimetric analyses.局限性小细胞肺癌前瞻性随机研究的胸部放疗靶区及剂量学分析的最终报告。
Cancer. 2020 Feb 15;126(4):840-849. doi: 10.1002/cncr.32586. Epub 2019 Nov 12.
4
Surgery for limited-stage small-cell lung cancer.局限期小细胞肺癌的手术治疗
Cochrane Database Syst Rev. 2017 Apr 21;4(4):CD011917. doi: 10.1002/14651858.CD011917.pub2.
5
Steep dose-response relationship for stage I non-small-cell lung cancer using hypofractionated high-dose irradiation by real-time tumor-tracking radiotherapy.采用实时肿瘤追踪放疗的大分割高剂量照射对I期非小细胞肺癌的陡峭剂量反应关系。
Int J Radiat Oncol Biol Phys. 2008 Feb 1;70(2):374-81. doi: 10.1016/j.ijrobp.2007.06.043. Epub 2007 Oct 29.
6
The complex relationship between lung tumor volume and survival in patients with non-small cell lung cancer treated by definitive radiotherapy: a prospective, observational prognostic factor study of the Trans-Tasman Radiation Oncology Group (TROG 99.05).根治性放疗治疗非小细胞肺癌患者的肿瘤体积与生存的复杂关系：澳大利亚和新西兰放射肿瘤学组（TROG 99.05）的一项前瞻性观察性预后因素研究。
Radiother Oncol. 2013 Mar;106(3):305-11. doi: 10.1016/j.radonc.2012.12.003. Epub 2013 Jan 16.
7
Lobectomy leads to optimal survival in early-stage small cell lung cancer: a retrospective analysis.肺叶切除术可显著提高早期小细胞肺癌患者的生存率：一项回顾性分析。
J Thorac Cardiovasc Surg. 2011 Sep;142(3):538-46. doi: 10.1016/j.jtcvs.2010.11.062.
8
9
High-dose-rate Three-dimensional Conformal Radiotherapy Combined with Active Breathing Control for Stereotactic Body Radiotherapy of Early-stage Non-small-cell Lung Cancer.高剂量率三维适形放疗联合主动呼吸控制用于早期非小细胞肺癌的立体定向体部放疗
Technol Cancer Res Treat. 2015 Dec;14(6):677-82. doi: 10.7785/tcrt.2012.500441. Epub 2014 Nov 26.
10
Early versus late chest radiotherapy for limited stage small cell lung cancer.局限期小细胞肺癌的早期与晚期胸部放疗
Cochrane Database Syst Rev. 2005 Jan 25;2004(1):CD004700. doi: 10.1002/14651858.CD004700.pub2.
引用本文的文献
1
＜Editors' Choice＞ Elective nodal irradiation versus involved field radiotherapy for limited disease small cell lung cancer: a single-institution experience.＜编辑精选＞局限期小细胞肺癌选择性淋巴结照射与累及野放疗：单机构经验。
Nagoya J Med Sci. 2022 May;84(2):327-338. doi: 10.18999/nagjms.84.2.327.
本文引用的文献
1
Imaging-based target volume reduction in chemoradiotherapy for locally advanced non-small-cell lung cancer (PET-Plan): a multicentre, open-label, randomised, controlled trial.基于影像学的局部晚期非小细胞肺癌放化疗靶区缩小（PET-Plan）：一项多中心、开放标签、随机、对照试验。
Lancet Oncol. 2020 Apr;21(4):581-592. doi: 10.1016/S1470-2045(20)30013-9. Epub 2020 Mar 12.
2
Final report of a prospective randomized study on thoracic radiotherapy target volume for limited-stage small cell lung cancer with radiation dosimetric analyses.局限性小细胞肺癌前瞻性随机研究的胸部放疗靶区及剂量学分析的最终报告。
Cancer. 2020 Feb 15;126(4):840-849. doi: 10.1002/cncr.32586. Epub 2019 Nov 12.
3
[Lung cancer and elective nodal irradiation: A solved issue?].[肺癌与选择性淋巴结照射：一个已解决的问题？]
Cancer Radiother. 2019 Oct;23(6-7):701-707. doi: 10.1016/j.canrad.2019.06.008. Epub 2019 Sep 6.
4
Association of Chemoradiotherapy With Outcomes Among Patients With Stage I to II vs Stage III Small Cell Lung Cancer: Secondary Analysis of a Randomized Clinical Trial.放化疗与局限期与广泛期小细胞肺癌患者结局的相关性：一项随机临床试验的二次分析。
JAMA Oncol. 2019 Mar 1;5(3):e185335. doi: 10.1001/jamaoncol.2018.5335. Epub 2019 Mar 14.
5
Concurrent once-daily versus twice-daily chemoradiotherapy in patients with limited-stage small-cell lung cancer (CONVERT): an open-label, phase 3, randomised, superiority trial.局限期小细胞肺癌患者同步每日一次与每日两次放化疗的比较（CONVERT）：一项开放标签、3期、随机、优效性试验
Lancet Oncol. 2017 Aug;18(8):1116-1125. doi: 10.1016/S1470-2045(17)30318-2. Epub 2017 Jun 20.
6
Impact of thoracic radiotherapy timing in limited-stage small-cell lung cancer: usefulness of the individual patient data meta-analysis.胸部放疗时机对局限期小细胞肺癌的影响：个体患者数据荟萃分析的效用
Ann Oncol. 2016 Oct;27(10):1818-28. doi: 10.1093/annonc/mdw263. Epub 2016 Jul 19.
7
Optimize and refine therapeutic index in radiation therapy: Overview of a century.优化和完善放射治疗的治疗指数：百年综述。
Cancer Treat Rev. 2016 Apr;45:58-67. doi: 10.1016/j.ctrv.2016.03.001. Epub 2016 Mar 7.
8
Comparison of 2 common radiation therapy techniques for definitive treatment of small cell lung cancer.比较两种常见的放射治疗技术，用于小细胞肺癌的根治性治疗。
Int J Radiat Oncol Biol Phys. 2013 Sep 1;87(1):139-47. doi: 10.1016/j.ijrobp.2013.05.040.
9
Phase III trial of concurrent thoracic radiotherapy with either first- or third-cycle chemotherapy for limited-disease small-cell lung cancer.局限期小细胞肺癌同期放化疗中第 1 或第 3 周期化疗的 III 期临床试验。
Ann Oncol. 2013 Aug;24(8):2088-92. doi: 10.1093/annonc/mdt140. Epub 2013 Apr 16.
10
Is involved-field radiotherapy based on CT safe for patients with limited-stage small-cell lung cancer?局限期小细胞肺癌的基于 CT 的累及野放疗安全吗？
Radiother Oncol. 2012 Feb;102(2):258-62. doi: 10.1016/j.radonc.2011.10.003. Epub 2011 Nov 5.
Zotero 插件